Skip to Content

Join the 'Herpes Zoster Iridocyclitis' group to help and get support from people like you.

Herpes Zoster Iridocyclitis News

There's a New Shingles Vaccine, Shingrix, -- Is It for You?

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – On the heels of approval of a better vaccine for the painful condition shingles, adults over 50 should plan to roll up their sleeves – again. The new vaccine, Shingrix, will likely be recommended even for those already inoculated with an older vaccine. An advisory panel of the U.S. Centers for Disease Control and Prevention recommended Wednesday that all adults 50 and older receive the new two-shot vaccine, just days after the U.S. Food and Drug Administration announced its approval of Shingrix. Shingrix, manufactured by GlaxoSmithKline, is more than 90 percent effective in preventing shingles, a painful skin disease that afflicts about one of every three people in the United States during their lifetime. If the CDC adopts the panel's recommendation, Shingrix will supplant the only other shingles vaccine available, the single-dose Merck product Zostavax. "The ... Read more

Related support groups: Herpes Zoster, Zostavax, Varicella-Zoster, Herpes Zoster Iridocyclitis, Herpes Zoster Otitis Externa, Shingrix, Herpes Zoster Meningitis, Herpes Zoster Myelitis, Herpes Zoster Peripheral Neuropathy

Expert Panel Recommends New Shingles Vaccine, Shingrix, as First-Line Treatment

Posted 26 Oct 2017 by Drugs.com

A new shingles vaccine that provides far more protection than its predecessor received the full blessing of a U.S. government vaccine advisory panel on Wednesday. In a close 8-7 vote, the Advisory Committee on Immunization Practices recommended that Shingrix be chosen over Zostavax as the shingles vaccine of choice in adults aged 50 and older, the Washington Post reported. Previously, a shingles vaccine had only been recommended for those aged 60 and older. The panel went even further, and recommended that anyone who has been vaccinated with the Zostavax vaccine be re-vaccinated with the Shingrix vaccine – that group numbers about 20 million people, the Post reported. In total, more than 40 million people will be affected by the new recommendations, the newspaper said. Shingles is an extraordinarily painful rash caused by the chickenpox virus. It tends to strike older adults. The U.S. ... Read more

Related support groups: Herpes Zoster, Zostavax, Herpes Zoster Iridocyclitis, Shingrix, Herpes Zoster Meningitis, Herpes Zoster Myelitis, Herpes Zoster Peripheral Neuropathy

New Shingles Vaccine, Shingrix, Approved by FDA

Posted 25 Oct 2017 by Drugs.com

A new, more effective shingles vaccine has been approved by the U.S. Food and Drug Administration. The new vaccine from GlaxoSmithKline will be the second shingles vaccine available in the U.S. market. The other is from Merck and was introduced in 2006, the Associated Press reported. Shingles is a painful condition caused by the chickenpox virus. Anyone who's had chickenpox carries the virus that causes shingles. A study funded by Glaxo found that the company's Shingrix vaccine prevented shingles in about 90 percent of people. Merck's Zostavax vaccine is about 50 percent effective, the AP reported. Shingrix will cost $280 for the required two shots. Zostavax costs $223. Most insurance plans cover the vaccination. Both vaccines are for adults 50 and older, but the Centers for Disease Control and Prevention recommends vaccination for people 60 and older, partly because vaccination loses ... Read more

Related support groups: Herpes Zoster, Zostavax, Herpes Zoster Iridocyclitis, Zoster Vaccine Live, Shingrix, Herpes Zoster - Prophylaxis, Zoster Vaccine (recombinant), Herpes Zoster Meningitis, Herpes Zoster Myelitis, Herpes Zoster Peripheral Neuropathy

Chickenpox, Shingles Vaccines Linked to Rare Eye Inflammation

Posted 25 Jan 2016 by Drugs.com

MONDAY, Jan. 25, 2016 – The vaccine for chickenpox and shingles has been linked to inflammation of the eye's cornea, but the number of such cases is small, a new study says. "Keratitis, or inflammation of the clear layer on the front of the eye, is a vision issue that can cause serious complications or even permanent damage to your vision if left untreated," Dr. Frederick Fraunfelder, chair of the ophthalmology department and director of the University of Missouri Eye Institute, said in a university news release. Researchers found 20 cases of keratitis in children and adults that occurred within a month of receiving a chickenpox or shingles vaccine. Symptoms of the disorder developed within 24 days of vaccination among adults. In children, symptoms began within 14 days of vaccination, the researchers said. The researchers said there is a probable relationship between the vaccine and ... Read more

Related support groups: Eye Conditions, Herpes Zoster, Zostavax, Varicella-Zoster, Corneal Ulcer, Eye Redness/Itching, Keratitis, Varicella Virus Vaccine, Corneal Abrasion, Herpes Zoster Iridocyclitis, Measles Virus Vaccine/Mumps Virus Vaccine/Rubella Virus Vaccine/Varicella Virus Vaccine, Vaccination and Prophlaxis, Zoster Vaccine Live, Visual Defect/Disturbance, ProQuad, Varivax, Varicella-Zoster - Prophylaxis

Ask a Question

Further Information

Related Condition Support Groups

Herpes Zoster

Related Drug Support Groups

prednisone, Deltasone, Sterapred, Liquid Pred, Sterapred DS, Meticorten, Orasone, Prednicen-M, Prednicot